BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2016 9:14:00 AM | Browse: 1482 | Download: 2140
Publication Name World Journal of Gastroenterology
Manuscript ID 25584
Country Taiwan
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials
Manuscript Source Unsolicited Manuscript
All Author List Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang and Ka-Wai Tam
Funding Agency and Grant Number
Corresponding Author Ka-Wai Tam, MD, PhD, Center for Evidence-based Health Care, Shuang Ho Hospital, Taipei Medical University, 291, Zhongzheng Road, Zhonghe District, New Taipei 23561, Taiwan. kelvintam@h.tmu.edu.tw
Key Words Helicobacter pylori eradication; Nonbismuth concomitant quadruple therapy; Peptic ulcer; Chinese region
Core Tip Helicobacter pylori (H. pylori) infection is highly prevalent in Chinese regions and associated with peptic ulcers. Currently, triple and sequential therapies have been widely used to eradicate H. pylori. Nonbismuth concomitant quadruple therapy is an alternative treatment with high efficacy. Our meta-analysis revealed that a higher H. pylori eradication rate was achieved with 7-d concomitant therapy than with 7-d triple therapy. The eradication rates of concomitant and sequential therapies were similar. However, the compliance with concomitant therapy was higher. Therefore, nonbismuth concomitant quadruple therapy should be the first-line treatment for H. pylori infection.
Publish Date 2016-06-13 09:14
Citation Lin LC, Hsu TH, Huang KW, Tam KW. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. World J Gastroenterol 2016; 22(23): 5445-5453
URL http://www.wjgnet.com/1007-9327/full/v22/i23/5445.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i23.5445
Full Article (PDF) WJG-22-5445.pdf
Full Article (Word) WJG-22-5445.doc